APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coronary Artery Bypass Grafts (CABG)

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.

Selected research

Market Outlook & Growth Opportunities

Global Coronary Artery Bypass Grafts (CABG) Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry ResearchCoronary Artery Bypass Grafts (CABG) Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Coronary Artery Bypass Grafts (CABG) Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Coronary Artery Bypass Grafts (CABG) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coronary Artery Bypass Grafts (CABG) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.

Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.

North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.

Read the full market overview

In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.

This report provides an overview of the global Coronary Artery Bypass Grafts (CABG) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coronary Artery Bypass Grafts (CABG) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coronary Artery Bypass Grafts (CABG) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Coronary Artery Bypass Grafts (CABG) market.

Coronary Artery Bypass Grafts (CABG) Segment by Company

Medtronic

Getinge Group

LivaNova

Terumo

Boston Scientific

Stryker

Edwards Lifesciences

Genesee Biomedical

Karl Storz GmbH

Coronary Artery Bypass Grafts (CABG) Segment by Type

Saphenous Vein Grafts

Internal Thoracic Artery Grafts

Other

Coronary Artery Bypass Grafts (CABG) Segment by Application

Traditional CABG

Nontraditional CABG

Coronary Artery Bypass Grafts (CABG) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Coronary Artery Bypass Grafts (CABG) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Coronary Artery Bypass Grafts (CABG) key companies, revenue, market share, and recent developments.

3. To split the Coronary Artery Bypass Grafts (CABG) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Coronary Artery Bypass Grafts (CABG) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Coronary Artery Bypass Grafts (CABG) significant trends, drivers, influence factors in global and regions.

6. To analyze Coronary Artery Bypass Grafts (CABG) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronary Artery Bypass Grafts (CABG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coronary Artery Bypass Grafts (CABG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronary Artery Bypass Grafts (CABG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coronary Artery Bypass Grafts (CABG) industry.

Chapter 3: Detailed analysis of Coronary Artery Bypass Grafts (CABG) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Coronary Artery Bypass Grafts (CABG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Coronary Artery Bypass Grafts (CABG) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Coronary Artery Bypass Grafts (CABG) Industry Trends Table 2. Coronary Artery Bypass Grafts (CABG) Industry Drivers Table 3. Coronary Artery Bypass Grafts (CABG) Industry Opportunities and Challenges Table 4. Coronary Artery Bypass Grafts (CABG) Industry Restraints Table 5. Global Coronary Artery Bypass Grafts (CABG) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Coronary Artery Bypass Grafts (CABG) Revenue Share by Company (2021-2026) Table 7. Global Coronary Artery Bypass Grafts (CABG) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Coronary Artery Bypass Grafts (CABG) Key Company Manufacturing Base & Headquarters Table 9. Global Coronary Artery Bypass Grafts (CABG) Company, Product Type & Application Table 10. Global Coronary Artery Bypass Grafts (CABG) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Coronary Artery Bypass Grafts (CABG) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Saphenous Vein Grafts Table 15. Significant Companies of Internal Thoracic Artery Grafts Table 16. Significant Companies of Other Table 17. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type (2021-2026) Table 21. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Traditional CABG Table 23. Significant Companies of Nontraditional CABG Table 24. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application (2021-2026) Table 28. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application (2027-2032) Table 29. Global Coronary Artery Bypass Grafts (CABG) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Region (2021-2026) Table 32. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Region (2027-2032) Table 34. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Coronary Artery Bypass Grafts (CABG) Sales Value Market Share by Country (2021-2026) Table 37. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Coronary Artery Bypass Grafts (CABG) Sales Value Market Share by Country (2027-2032) Table 39. Medtronic Company Information Table 40. Medtronic Business Overview Table 41. Medtronic Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Medtronic Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 43. Medtronic Recent Development Table 44. Getinge Group Company Information Table 45. Getinge Group Business Overview Table 46. Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Getinge Group Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 48. Getinge Group Recent Development Table 49. LivaNova Company Information Table 50. LivaNova Business Overview Table 51. LivaNova Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. LivaNova Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 53. LivaNova Recent Development Table 54. Terumo Company Information Table 55. Terumo Business Overview Table 56. Terumo Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Terumo Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 58. Terumo Recent Development Table 59. Boston Scientific Company Information Table 60. Boston Scientific Business Overview Table 61. Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Boston Scientific Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 63. Boston Scientific Recent Development Table 64. Stryker Company Information Table 65. Stryker Business Overview Table 66. Stryker Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Stryker Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 68. Stryker Recent Development Table 69. Edwards Lifesciences Company Information Table 70. Edwards Lifesciences Business Overview Table 71. Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 73. Edwards Lifesciences Recent Development Table 74. Genesee Biomedical Company Information Table 75. Genesee Biomedical Business Overview Table 76. Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 78. Genesee Biomedical Recent Development Table 79. Karl Storz GmbH Company Information Table 80. Karl Storz GmbH Business Overview Table 81. Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 83. Karl Storz GmbH Recent Development Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Coronary Artery Bypass Grafts (CABG) Product Image Figure 2. Global Coronary Artery Bypass Grafts (CABG) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coronary Artery Bypass Grafts (CABG) Market Size (2021-2032) & (US$ Million) Figure 4. Global Coronary Artery Bypass Grafts (CABG) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Saphenous Vein Grafts Image Figure 8. Internal Thoracic Artery Grafts Image Figure 9. Other Image Figure 10. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type (2021-2032) Figure 13. Traditional CABG Image Figure 14. Nontraditional CABG Image Figure 15. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application (2021-2032) Figure 18. Global Coronary Artery Bypass Grafts (CABG) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Coronary Artery Bypass Grafts (CABG) Sales Value (2021-2032) & (US$ Million) Figure 21. North America Coronary Artery Bypass Grafts (CABG) Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Coronary Artery Bypass Grafts (CABG) Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Coronary Artery Bypass Grafts (CABG) Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Coronary Artery Bypass Grafts (CABG) Sales Value (2021-2032) & (US$ Million) Figure 27. South America Coronary Artery Bypass Grafts (CABG) Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Saphenous Vein Grafts
  • Internal Thoracic Artery Grafts
  • Other
Applications
  • Traditional CABG
  • Nontraditional CABG
Companies covered
  • Medtronic
  • Getinge Group
  • LivaNova
  • Terumo
  • Boston Scientific
  • Stryker
  • Edwards Lifesciences
  • Genesee Biomedical
  • Karl Storz GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Coronary Artery Bypass Grafts (CABG) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Coronary Artery Bypass Grafts (CABG) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Coronary Artery Bypass Grafts (CABG) Market Dynamics
  1. 2.1 Coronary Artery Bypass Grafts (CABG) Industry Trends
  2. 2.2 Coronary Artery Bypass Grafts (CABG) Industry Drivers
  3. 2.3 Coronary Artery Bypass Grafts (CABG) Industry Opportunities and Challenges
  4. 2.4 Coronary Artery Bypass Grafts (CABG) Industry Restraints
3 Coronary Artery Bypass Grafts (CABG) Market by Company
  1. 3.1 Global Coronary Artery Bypass Grafts (CABG) Company Revenue Ranking in 2025
  2. 3.2 Global Coronary Artery Bypass Grafts (CABG) Revenue by Company (2021-2026)
  3. 3.3 Global Coronary Artery Bypass Grafts (CABG) Company Ranking (2024-2026)
  4. 3.4 Global Coronary Artery Bypass Grafts (CABG) Company Manufacturing Base and Headquarters
  5. 3.5 Global Coronary Artery Bypass Grafts (CABG) Company Product Type and Application
  6. 3.6 Global Coronary Artery Bypass Grafts (CABG) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Coronary Artery Bypass Grafts (CABG) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Coronary Artery Bypass Grafts (CABG) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Coronary Artery Bypass Grafts (CABG) Market by Type
  1. 4.1 Coronary Artery Bypass Grafts (CABG) Type Introduction
  2. 4.1.1 Saphenous Vein Grafts
  3. 4.1.2 Internal Thoracic Artery Grafts
  4. 4.1.3 Other
  5. 4.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type
  6. 4.2.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2021-2032)
  8. 4.2.3 Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type (2021-2032)
5 Coronary Artery Bypass Grafts (CABG) Market by Application
  1. 5.1 Coronary Artery Bypass Grafts (CABG) Application Introduction
  2. 5.1.1 Traditional CABG
  3. 5.1.2 Nontraditional CABG
  4. 5.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application
  5. 5.2.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2021-2032)
  7. 5.2.3 Global Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application (2021-2032)
6 Coronary Artery Bypass Grafts (CABG) Regional Value Analysis
  1. 6.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Coronary Artery Bypass Grafts (CABG) Sales Value (2021-2032)
  7. 6.3.2 North America Coronary Artery Bypass Grafts (CABG) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Coronary Artery Bypass Grafts (CABG) Sales Value (2021-2032)
  10. 6.4.2 Europe Coronary Artery Bypass Grafts (CABG) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Coronary Artery Bypass Grafts (CABG) Sales Value (2021-2032)
  16. 6.6.2 South America Coronary Artery Bypass Grafts (CABG) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value Share by Country, 2025 VS 2032
7 Coronary Artery Bypass Grafts (CABG) Country-level Value Analysis
  1. 7.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Coronary Artery Bypass Grafts (CABG) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Coronary Artery Bypass Grafts (CABG) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Coronary Artery Bypass Grafts (CABG) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Coronary Artery Bypass Grafts (CABG) Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Getinge Group
  8. 8.2.1 Getinge Group Company Information
  9. 8.2.2 Getinge Group Business Overview
  10. 8.2.3 Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Getinge Group Coronary Artery Bypass Grafts (CABG) Product Portfolio
  12. 8.2.5 Getinge Group Recent Developments
  13. 8.3 LivaNova
  14. 8.3.1 LivaNova Company Information
  15. 8.3.2 LivaNova Business Overview
  16. 8.3.3 LivaNova Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 LivaNova Coronary Artery Bypass Grafts (CABG) Product Portfolio
  18. 8.3.5 LivaNova Recent Developments
  19. 8.4 Terumo
  20. 8.4.1 Terumo Company Information
  21. 8.4.2 Terumo Business Overview
  22. 8.4.3 Terumo Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Coronary Artery Bypass Grafts (CABG) Product Portfolio
  24. 8.4.5 Terumo Recent Developments
  25. 8.5 Boston Scientific
  26. 8.5.1 Boston Scientific Company Information
  27. 8.5.2 Boston Scientific Business Overview
  28. 8.5.3 Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Boston Scientific Coronary Artery Bypass Grafts (CABG) Product Portfolio
  30. 8.5.5 Boston Scientific Recent Developments
  31. 8.6 Stryker
  32. 8.6.1 Stryker Company Information
  33. 8.6.2 Stryker Business Overview
  34. 8.6.3 Stryker Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Stryker Coronary Artery Bypass Grafts (CABG) Product Portfolio
  36. 8.6.5 Stryker Recent Developments
  37. 8.7 Edwards Lifesciences
  38. 8.7.1 Edwards Lifesciences Company Information
  39. 8.7.2 Edwards Lifesciences Business Overview
  40. 8.7.3 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Product Portfolio
  42. 8.7.5 Edwards Lifesciences Recent Developments
  43. 8.8 Genesee Biomedical
  44. 8.8.1 Genesee Biomedical Company Information
  45. 8.8.2 Genesee Biomedical Business Overview
  46. 8.8.3 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Product Portfolio
  48. 8.8.5 Genesee Biomedical Recent Developments
  49. 8.9 Karl Storz GmbH
  50. 8.9.1 Karl Storz GmbH Company Information
  51. 8.9.2 Karl Storz GmbH Business Overview
  52. 8.9.3 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Product Portfolio
  54. 8.9.5 Karl Storz GmbH Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst